ID   PER-106
AC   CVCL_8904
SY   PER 106
DR   IARC_TP53; 23832
DR   Wikidata; Q54947171
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=1581878;
CC   Doubling time: 10.5 days (Note=For non-adherent), >30 days (Note=For adherent) (PubMed=1581878).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8905 ! PER-107
OI   CVCL_8906 ! PER-108
SX   Male
AG   1Y5M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
RX   DOI=10.1007/0-306-46872-7_2;
RA   Thiele C.J.;
RT   "Neuroblastoma.";
RL   (In book chapter) Human cell culture. Vol. 1. Cancer cell lines part 1; Masters J.R.W., Palsson B.O. (eds.); pp.21-53; Kluwer Academic Publishers; New York; USA (1999).
//
RX   PubMed=1581878; DOI=10.1016/0165-4608(92)90205-M;
RA   Kees U.R., Ford J., Dawson V.M., Ranford P.R., Armstrong J.A.;
RT   "Three neuroblastoma cell lines established from consecutive samples
RT   of one patient which show distinct morphologic features, MYCN
RT   amplification, and surface marker expression.";
RL   Cancer Genet. Cytogenet. 59:119-127(1992).
//